To avoid collateral effects, more specific modulators of amino acids metabolism can be developed, through the use of monoclonal antibodies, mimetic peptides that activate receptors, proteolysis-targeting chimera degraders, and/or antisense nucleotides targeting genes (receptors, transporters, or enzymes) [252,253,254,255]
Silybin and silymarin have been shown to exhibit antimicrobial activity against gram-positive bacteria and increase the effect of resistant S.aureus to antibiotics (5,10)
I only use the enzymes after larger meals, high-sulfur food days, or major calorie anomalies
Higher weight loss (1% reduction in weight from baseline was associated with a 3.1% [95% CI, 2.9%-3.2%] lower hazard of discontinuation for patients with type 2 diabetes and a 3.3% [95% CI, 3.2%-3.5%] lower hazard of discontinuation for patients without type 2 diabetes) and higher income (type 2 diabetes only
It is possible that participants in the group with neither weight loss nor glucose reduction discontinued or only sporadically used the drug, so we focused on those who achieved a reduction in either outcome, as it is more likely that these individuals used the drug as prescribed
If you experience night sweats while taking GLP-1 therapy, other medical causes should be investigated, including hypoglycemia, infections, hormonal changes, or medication interactions
